TAYLOR DALE: Open Payments
NPI 1013482033 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 72 payments from 13 companies in 2025. Trend: 2023 $2,035 · 2024 $1,978 · 2025 $2,073
Food & beverage: $1,983Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $643 |
| Janssen Biotech, Inc. | 17 | $418 |
| Amgen Inc. | 28 | $360 |
| Mallinckrodt Hospital Products Inc. | 2 | $250 |
| GENZYME CORPORATION | 1 | $108 |
| UCB, Inc. | 3 | $75 |
| Lilly USA, LLC | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
Products named: RINVOQ, TREMFYA, ACTHAR, OTEZLA, SKYRIZI, KEVZARA, ENBREL, Bimzelx.
Industry payments across NC — which companies pay providers there.
